Nono Shota, Nakamura Yukinori, Fujioka Yuka, Yamamoto Kaoru, Tokunaga Yoshihiro, Okamura Kohei, Sakai Kohei, Ando Taishi, Nakabayashi Hiroko, Ohta Yasuharu, Yujiri Toshiaki
Third Department of Internal Medicine, Yamaguchi University Hospital, 1-1-1 Minamikogushi, Ube, 755-8505, Yamaguchi, Japan.
Division of Blood Transfusion, Yamaguchi University Hospital, Ube, Japan.
Sci Rep. 2025 Jul 31;15(1):27982. doi: 10.1038/s41598-025-12373-0.
The association between organ volumes prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) and patient outcomes following the procedure remains unclear. Therefore, we evaluated the association between organ volumes-including of the kidneys, spleen, and liver-as evaluated via three-dimensional computed tomography (3D-CT), and outcomes following allo-HSCT. We retrospectively assessed data from 90 patients who underwent allo-HSCT for the first time at Yamaguchi University Hospital between 2016 and 2022. Organ volumes were adjusted to each patient's body surface area, and cutoff values were determined via receiver operating characteristic curve analyses for overall survival (OS). In our multivariate analyses, kidney volume (KV) of ≥ 198 mL/m and spleen volume (SV) of < 60 mL/m represented independent risk factors for worse OS (hazard ratio [HR]: 2.80, 95% confidence interval [CI]: 1.27-6.14; and HR: 2.06, 95% CI: 1.14-3.70, respectively), while a KV of ≥ 198 mL/m was an independent risk factor for non-relapse mortality (HR: 16.93, 95% CI: 3.88-73.91). The incidence of sinusoidal obstruction syndrome was also higher in the patients with KVs of ≥ 198 mL/m vs. those that were < 198 mL/m (10.5% vs. 0.0%, P < 0.01). We found that large KVs and small SVs, but not liver volumes as measured via 3D-CT, correlated with worse outcomes following allo-HSCT.
异基因造血干细胞移植(allo-HSCT)前器官体积与移植后患者预后之间的关联尚不清楚。因此,我们评估了通过三维计算机断层扫描(3D-CT)评估的肾脏、脾脏和肝脏等器官体积与allo-HSCT后预后之间的关联。我们回顾性分析了2016年至2022年在山口大学医院首次接受allo-HSCT的90例患者的数据。将器官体积调整为每位患者的体表面积,并通过生存曲线分析确定总生存期(OS)的临界值。在我们的多变量分析中,肾脏体积(KV)≥198 mL/m²和脾脏体积(SV)<60 mL/m²是OS较差的独立危险因素(风险比[HR]:2.80,95%置信区间[CI]:1.27-6.14;HR:2.06,95%CI:1.14-3.70),而KV≥198 mL/m²是非复发死亡率的独立危险因素(HR:16.93,95%CI:3.88-73.91)。KV≥198 mL/m²的患者与<198 mL/m²的患者相比,窦性阻塞综合征的发生率也更高(10.5%对0.0%,P<0.01)。我们发现,大的KV和小的SV与allo-HSCT后较差的预后相关,但通过3D-CT测量的肝脏体积与预后无关。